We always have something going on at Juno.
Want to keep up with our most recent developments?
Have a read of our latest news, new product launches and business news.
Filter News by:

Bridgewest Appoint Juno Pharmaceuticals as Sales and Marketing Partner

Bridgewest has appointed Juno Pharmaceuticals Pty Ltd (Juno) as Bridgewest’s exclusive sales and marketing partner in Australia and New Zealand for range of widely used sterile injectable products. Read more

New Product Launch: Pomolide™ (pomalidomide)

Juno Pharmaceuticals is pleased to announce the launch of Pomolide™ (pomalidomide) oral capsules, in four strengths: 1 mg, 2 mg, 3 mg and 4 mg. Read more

New Product Launch: Clozitor™ (clozapine)

Juno Pharmaceuticals is pleased to announce the launch of Clozitor™ (clozapine) oral tablets, in four strengths: 25 mg, 50 mg, 100 mg and 200 mg. Read more

Parecoxib Juno: Australian Development, Global Potential

Juno Pharmaceuticals has been marketing Parecoxib Juno in Australia since 2018 and subsequently acquired the global rights for the product. Based on the local success including an expanding market, Juno has set its sights on international markets and is actively pursuing an out-licensing strategy for the molecule. Read more

11 New Products Launched in 2021 – A New Record for Juno

Juno’s rapid growth over the past few years is largely related to the company’s focus on launching new products into Australia and New Zealand. In the past five years, the size of Juno’s product portfolio has tripled. Read more